Skip to main content
Log in

Tumor cytotoxicity of human monocyte membrane-bound interleukin-1α induced by synergistic actions of interferon-γ and synthetic acyltripeptide, FK-565

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Human blood monocytes were isolated by counter-flow centrifugal elutriation from healthy donors and these noncytotoxic monocytes were rendered tumoricidal to allogeneic melanoma (A375) cells by activation with a synthetic acyltripeptide (FK-565), as assessed by measuring release of [125I]iododeoxyuridine in 72 h. When monocytes were treated with FK-565 for 16 h, and then fixed with paraformaldehyde, they showed cytotoxicity to A375 melanoma cells. The fixed-monocyte-mediated cytotoxicity to A375 cells was induced by the synergistic actions of FK-565 and recombinant interferon-γ (rIFN-γ), but not other cytokines [rIFN-αA, rIFN-β, tumor necrosis factor (TNF), interleukin (IL)-2, -3 and -6]. For synergistic activation of monocytes with induction of a membrane-associated antitumor monokine, the monocytes had to be incubated first with rIFN-γ and then with FK-565. FK-565 also acted synergistically with rIFN-γ to stimulate monocytes to produce membrane-associated IL-1 activity, which induced C3H/HeJ thymocyte blastogenesis in response to phytohemagglutinin P. The tumoricidal and thymocytestimulating activities of the fixed monocytes were almost completely inhibited by a specific anti-(IL-1α) antiserum, but not by a specific anti-(IL-1β) antiserum or monoclonal anti-TNF antibody. These results suggest that membrane-associated IL-1α of human blood monocytes can be induced by two activation signals (rIFN-γ then FK-565) at their suboptimal concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

IL:

interleukin

IFN:

interferon

TNF:

tumor necrosis factor

References

  1. Bakouche O, Brown DC, Lachman LB (1987) Subcellular localization of human monocyte interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL1 release. J Immunol 138:4249

    Google Scholar 

  2. Bakouche O, Ichinose Y, Heicappel R, Fidler IJ, Lachman LB (1988) Plasma membrane-associated tumor necrosis factor: a non-integral membrane protein possibly bound to its own receptors. J Immunol 140:1142

    Google Scholar 

  3. Bakouche O, Lachman LB, Knowles RD, Kleinerman ES (1988) Cytotoxic liposomes: membrane interleukin 1 presented in multilamellar vesicles. J Immunol (in press)

  4. Conlon PJ, Grabstein KH, Alpert A, Prickett KS, Hopp TP, Gillis S (1987) Localization of human mononuclear cell inter leukin 1. J Immunol 139:98

    Google Scholar 

  5. Dean RT, Virelizier JL (1983) Interferon as a macrophage-activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals. Clin Exp Immunol 51:501

    Google Scholar 

  6. Decker T, Lohmann-Matthes M, Gifford GE (1987) Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immunol 61:443

    Google Scholar 

  7. Dinarello CA (1985) Interleukin 1. Rev Infect Dis 6:51

    Google Scholar 

  8. Espevik T, Nissen-Mayer J (1987) Tumor necrosis factor-like activity on paraformaldehyde-fixed monocyte monolayers. Immunology 61:443

    Google Scholar 

  9. Feinman R, Henriksen-DeStefano D, Tsujimoto M, Vilcek J (1987) Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 138:635

    Google Scholar 

  10. Fidler IJ (1985) Macrophages and metastasis — a biological approach to cancer therapy. Presidental address. Cancer Res 45:4714

    Google Scholar 

  11. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417

    CAS  PubMed  Google Scholar 

  12. Henmi K, Aratani M, Takeno H, Okada S, Miyazaki Y, Nakaguchi O, Kitaura Y, Hashimoto M (1982) Studies on a new immunoactive peptide, FK-156. 4. Synthesis of FK-156 and its geometric isomer. J Antibiot (Tokyo) 35:130

    Google Scholar 

  13. Hinuma S, Onda H, Naruo K, Ichimori Y, Koyama M, Tsukamoto K (1982) Translation of interleukin 2 mRNA from human peripheral blood leukocytes in Xenopus oocytes. Biochem Biophys Res Commun 109:363

    Google Scholar 

  14. Hurme M (1987) Membrane-associated interleukin 1 is required for the activation of T cells in the anti-CD3 antibody-induced T cell response. J Immunol 139:1168

    Google Scholar 

  15. Inamura N, Nakahara K, Kino T, Gotoh T, Kawamura I, Aoki H, Imanaka H, Sone S (1985) Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565. J Biol Resp Modif 4:408

    Google Scholar 

  16. Jett JR, Mantovani A, Herberman RB (1980) Augmentation of human monocyte-mediated cytolysis by interferon. Cell Immunol 54:425

    Google Scholar 

  17. Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER (1985) Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 82:120

    Google Scholar 

  18. Kurt-Jones EA, Virgin IV HW, Unanue ER (1985) Relationship of macrophage Ia and membrane IL-1 expression to antigen presentation. J Immunol 135:3652

    Google Scholar 

  19. Kurt-Jones EA, Virgin IV HW, Unanue ER (1986) In vivo and in vitro expression of macrophage membrane interleukin 1 in response to soluble and particulate stimuli. J Immunol 137:10

    Google Scholar 

  20. Lachman LB, Dinarello CA, Llansa ND, Fidler IJ (1986) Natural and recombinant human interleukin 1-β is cytotoxic for human melanoma cells. J Immunol 136:3098

    Google Scholar 

  21. Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J (1983) Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol 131:2821

    Google Scholar 

  22. Lovett D, Kozan B, Hadan M, Resch K, Gemsa D (1986) Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol 136:340

    Google Scholar 

  23. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641

    Google Scholar 

  24. Mine Y, Yokota Y, Wakai Y, Fukuda S, Nishida M, Gotoh S, Kuwahara S (1983) Immunoactive peptide, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice. J Antibiot (Tokyo) 36:1045

    Google Scholar 

  25. Nishida T, Nishino N, Takano M, Kawai K, Bando K, Masui Y, Nakai S, Hirai Y (1987) cDNA cloning of IL-1α and IL-1β from mRNA of U937 cell line. Biochem Biophys Res Commun 143:345

    Google Scholar 

  26. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ (1985) Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135:3962

    Google Scholar 

  27. Sone S (1986) Role of alveolar macrophages in pulmonary neoplasias. Biochim Biophys Acta 823:227

    Google Scholar 

  28. Sone S, Mutsuura S, Ogawara M, Utsugi T, Tsubura E (1984) Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state. Cancer Immunol Immunother 18:169

    Google Scholar 

  29. Sone S, Tandon P, Utsugi T, Ogawara M, Shimizu E, Nii A, Ogura T (1986) Synergism of recombinant human interferon gamma with liposome-encapsulated muramyl tripeptide in activation of the tumoricidal properties of human monocytes. Int J Cancer 38:495

    Google Scholar 

  30. Sone S, Okubo A, Inamura N, Nii A, Ogura T (1988) Synergism of synthetic acyltripeptide and its analogs with recombinant interferon γ for activation of antitumor properties of human blood monocytes. Cancer Immunol Immunother 27:33

    Google Scholar 

  31. Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y (1987) Highly sensitive sandwich enzyme immunoassay for human interleukin 1β (hIL-1β) in urine using affinity-purified anti-hIL-1β Fab'-peroxidase conjugate. Clin Chim Acta 166:237

    Google Scholar 

  32. Tandon P, Utsugi T, Sone S (1986) Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide. Cancer Res 46:5039

    Google Scholar 

  33. Utsugi T, Sone S (1986) Comparative analysis of the priming effect of human interferon gamma, alpha and beta on synergism with muramyl dipeptide analog for antitumor expression of human blood monocytes. J Immunol 136:1117

    Google Scholar 

  34. Ziegler-Heitbrock HW, Moler A, Linke RP, Haas JG, Rieber EP, Riethmuller G (1986) Tumor necrosis factor as effector molecule in monocyte-mediated cytotoxicity. Cancer Res 46:5947

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inamura, N., Sone, S., Okubo, A. et al. Tumor cytotoxicity of human monocyte membrane-bound interleukin-1α induced by synergistic actions of interferon-γ and synthetic acyltripeptide, FK-565. Cancer Immunol Immunother 28, 164–170 (1989). https://doi.org/10.1007/BF00204984

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00204984

Keywords

Navigation